ACAD

ACADIA PHARMACEUTICALS INC

Healthcare | Mid Cap

$0.25

EPS Forecast

$268.6

Revenue Forecast

Announcing earnings for the quarter ending 2024-12-31 soon

Market expectations

EPS Expectation:

$0.25

Revenue Expectation:

$268.6

EPS Surprise Expectation:

$0.031

Revenue Surprise Expectation:

$1

Post-release price volatility - High

Post-release Overnight Move:

±8.8%

Post-release 1-week Move:

Expected price impact

If company results match EPS & revs consensus exactly:

If company results match Proximilar expectations exactly:

Earnings volatility

EPS standard deviation:

Revenue standard deviation: